Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Senatore

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Vaccines|November 27, 2021
Sweet Syndrome Following SARS-CoV2 VaccinationMaria Efenesia Baffa, Roberto Maglie, Neri Giovannozzi, et al.
Skin Health and Disease|November 28, 2025
Baricitinib improved morphoea manifestations in a patient with alopecia areata universalisVincenzina Rubino, Maria E Baffa, Carlo Pipitò, et al.
The Indian Journal of Surgery|September 2, 2014
An entirely echo-guided technique for totally implantable access port positioningGian Domenico Arzu, Federico Coccolini, Michele Rossi, et al.
Italian Journal of Dermatology and Venereology|March 27, 2026
The role of serological investigations in the diagnosis of bullous pemphigoid: a retrospective studyCarlo Pipitò, Giuseppe Pipitò, Maria E Baffa, et al.
Clinical and Experimental Dermatology|December 10, 2021
Myelodysplasia cutis as the presenting sign of chronic myelomonocytic leukaemiaRoberto Maglie, Stefano Senatore, Gioia Di Stefano, et al.
Journal of Clinical Medicine|July 27, 2022
Rituximab in Mucous Membrane Pemphigoid: A Monocentric Retrospective Study in 10 Patients with Severe/Refractory DiseaseMaria Efenesia Baffa, Alberto Corrà, Roberto Maglie, et al.
Frontiers in Immunology|May 20, 2022
Case Report: Bullous Pemphigoid Associated With Morphea and Lichen Sclerosus: Coincidental Diseases or Pathogenetic Association?Roberto Maglie, Maria Efenesia Baffa, Francesca Montefusco, et al.
The British Journal of Dermatology|August 12, 2025
Safety, tolerability, pharmacokinetics, and pharmacodynamic effects of desmoglein 3-peptide-coupled tolerizing nanoparticles in pemphigusDario Didona, Christoph Hudemann, Holger Garn, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Vaccines|November 27, 2021
Sweet Syndrome Following SARS-CoV2 VaccinationMaria Efenesia Baffa, Roberto Maglie, Neri Giovannozzi, et al.
Skin Health and Disease|November 28, 2025
Baricitinib improved morphoea manifestations in a patient with alopecia areata universalisVincenzina Rubino, Maria E Baffa, Carlo Pipitò, et al.
The Indian Journal of Surgery|September 2, 2014
An entirely echo-guided technique for totally implantable access port positioningGian Domenico Arzu, Federico Coccolini, Michele Rossi, et al.
Italian Journal of Dermatology and Venereology|March 27, 2026
The role of serological investigations in the diagnosis of bullous pemphigoid: a retrospective studyCarlo Pipitò, Giuseppe Pipitò, Maria E Baffa, et al.
Clinical and Experimental Dermatology|December 10, 2021
Myelodysplasia cutis as the presenting sign of chronic myelomonocytic leukaemiaRoberto Maglie, Stefano Senatore, Gioia Di Stefano, et al.
Journal of Clinical Medicine|July 27, 2022
Rituximab in Mucous Membrane Pemphigoid: A Monocentric Retrospective Study in 10 Patients with Severe/Refractory DiseaseMaria Efenesia Baffa, Alberto Corrà, Roberto Maglie, et al.
Frontiers in Immunology|May 20, 2022
Case Report: Bullous Pemphigoid Associated With Morphea and Lichen Sclerosus: Coincidental Diseases or Pathogenetic Association?Roberto Maglie, Maria Efenesia Baffa, Francesca Montefusco, et al.
The British Journal of Dermatology|August 12, 2025
Safety, tolerability, pharmacokinetics, and pharmacodynamic effects of desmoglein 3-peptide-coupled tolerizing nanoparticles in pemphigusDario Didona, Christoph Hudemann, Holger Garn, et al.
Pageof 1